operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-17Feb2022 Full

Page 143

Appendix G: Vaccination site screening questions We encourage you to screen both staff and consumers for risk of exposure to COVID-19 and COVID-19 symptoms. Screening is critical to breaking the chain of transmission of COVID-19 and maintaining staff and consumer safety. Figure G.1 below details the recommended screening questions and process. Please note: In the event of COVID-19 Alert Level changes, additional advice will be formulated by local public health units and the Ministry. Figure G.1– recommended screening questions Q1 – Do you have symptoms of COVID-19?

Follow link to COVID-19 Case definition

If a client has any symptoms suggestive of COVID-19, defer vaccination and do not permit entry to the site. Recommend they get a test and self-isolate pending the result.

If no symptoms, continue to the next question. Q2 – Have you been to any contact tracing locations of interest within time periods of concern?

Follow link to Current contact tracing locations of interest

If an individual has attended any locations of interest within the defined time periods; defer vaccination, do not permit entry to the site, and advise them to follow recommendations and guidance from the Ministry/public health services.

If no symptoms, continue to the next question. Q3 – Have you been requested to stay at home or to self-isolate?

If yes, defer vaccination and do not permit entry to the site. Recommend continuing to follow the stay at home/self-isolation plan. If no symptoms, continue to the next question. Q4 – Are you currently waiting on a COVID-19 test result?

If yes, defer vaccination and do not permit entry to the site. Recommend rebooking once a negative test result has been received, and they have been told they no longer need to stay at home/self-isolate. If no, proceed to vaccinate as per the Operating Guidelines.

Version 33.0 Page 143


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Document version control

2min
pages 155-156

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 153-154

Appendix J: Risk mitigations for vaccination sites

2min
page 152

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 140-141

Appendix D: Logistics and inventory management

1min
page 139

Appendix G: Vaccination site screening questions

1min
page 143

Variations

1min
page 126

Incidents

6min
pages 121-125

National Immunisation Booking System

11min
pages 115-120

Affected persons under the Vaccinations Order

4min
pages 112-114

COVID-19 Trial Vaccinations

1min
page 111

Home vaccinations

2min
pages 109-110

Mobile vaccination team

1min
page 108

Vaccination in Hospital

1min
page 107

Vaccination and Surveillance Testing

1min
page 106

Vaccination in high-risk or screened ‘positive’ consumers

4min
pages 102-104

Third primary dose for severely immunocompromised

1min
page 105

Section E: Additional programme guidance, variations and incidents

1min
page 101

AstraZeneca Vaccine administration and observation

7min
pages 95-100

AstraZeneca Preparation of doses

2min
pages 93-94

AstraZeneca Operational phase

1min
page 92

Booking and scheduling

1min
page 91

Section D: AstraZeneca COVID-19 Vaccine

1min
page 90

Paediatric Pfizer Vaccine administration and observation

8min
pages 85-89

Paediatric Pfizer Preparation of doses

3min
pages 82-84

Pfizer Vaccine administration and observation

12min
pages 69-77

Pfizer Preparation of doses

4min
pages 66-68

Pfizer Operational phase

2min
pages 63-64

Protecting security and privacy

1min
page 62

Vaccinating consumers aged 12 to 15 years

1min
page 65

Booking and scheduling

2min
pages 60-61

Becoming a COVID-19 Vaccination site

1min
page 58

Site readiness and closure

1min
page 57

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 55-56

COVID-19 Immunisation Register

3min
pages 27-29

Logistics

1min
page 30

Vaccine storage and handling

7min
pages 37-42

Infection prevention and control (IPC

2min
pages 25-26

Preparing the vaccination workforce

7min
pages 20-24

Equipment ordering and demand planning

7min
pages 31-36

Site considerations

7min
pages 16-19

Section A: Ready to vaccinate

1min
page 13
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.